(GENI) Genius Sports - Ratings and Ratios
Live Data, Odds, Streaming, Integrity, Risk
GENI EPS (Earnings per Share)
GENI Revenue
Description: GENI Genius Sports
Genius Sports Ltd (NYSE:GENI) is a leading provider of technology-led products and services to the sports, sports betting, and sports media industries, offering a range of innovative solutions that enable the collection, integration, and distribution of live sports data, streaming, and integrity services.
The companys comprehensive suite of services includes live sports data collection, pre-game and in-game odds feeds, risk management, live streaming, and digital marketing campaign optimization, catering to the needs of sports leagues, betting operators, and media companies. With a strong foundation in technology infrastructure, Genius Sports has established itself as a key player in the sports data and streaming market.
From a financial perspective, Genius Sports has demonstrated significant growth, with a market capitalization of $2.66 billion USD. To further evaluate the companys performance, we can examine key performance indicators (KPIs) such as revenue growth rate, customer acquisition cost, and customer lifetime value. For instance, a high revenue growth rate would indicate the companys ability to expand its customer base and increase its market share. Additionally, a low customer acquisition cost and high customer lifetime value would suggest efficient sales and marketing strategies, as well as strong customer retention.
To assess the companys valuation, we can consider metrics such as the price-to-sales (P/S) ratio, enterprise value-to-EBITDA (EV/EBITDA) ratio, and dividend yield. Given the companys forward P/E ratio of 204.08, it is essential to analyze the underlying drivers of this valuation multiple, such as expected earnings growth and industry comparables. Furthermore, examining the companys return on equity (ROE) of -7.65% and its implications on shareholder value can provide valuable insights.
By analyzing these KPIs and valuation metrics, we can gain a more comprehensive understanding of Genius Sports financial health, competitive positioning, and growth prospects, ultimately informing investment decisions.
GENI Stock Overview
| Market Cap in USD | 3,009m |
| Sub-Industry | Interactive Media & Services |
| IPO / Inception | 2021-04-21 |
GENI Stock Ratings
| Growth Rating | 72.6% |
| Fundamental | 42.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 31.0% |
| Analyst Rating | 4.67 of 5 |
GENI Dividends
Currently no dividends paidGENI Growth Ratios
| Growth Correlation 3m | 85.7% |
| Growth Correlation 12m | 87.5% |
| Growth Correlation 5y | -16.4% |
| CAGR 5y | 44.76% |
| CAGR/Max DD 3y | 1.06 |
| CAGR/Mean DD 3y | 3.40 |
| Sharpe Ratio 12m | 0.32 |
| Alpha | 0.00 |
| Beta | 0.994 |
| Volatility | 46.21% |
| Current Volume | 5249.7k |
| Average Volume 20d | 4295.4k |
| Stop Loss | 11.7 (-4.7%) |
| Signal | -0.09 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-77.9m TTM) > 0 and > 6% of Revenue (6% = 33.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 5.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 40.64% (prev 17.57%; Δ 23.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 53.3m > Net Income -77.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (253.2m) change vs 12m ago 10.35% (target <= -2.0% for YES) |
| Gross Margin 23.50% (prev 17.05%; Δ 6.45pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.95% (prev 62.02%; Δ 5.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1074 (EBITDA TTM -23.2m / Interest Expense TTM 80.0k) >= 6 (WARN >= 3) |
Altman Z'' -9.22
| (A) 0.24 = (Total Current Assets 394.6m - Total Current Liabilities 167.6m) / Total Assets 927.8m |
| (B) -1.24 = Retained Earnings (Balance) -1.15b / Total Assets 927.8m |
| warn (B) unusual magnitude: -1.24 — check mapping/units |
| (C) -0.10 = EBIT TTM -85.9m / Avg Total Assets 821.9m |
| (D) -5.80 = Book Value of Equity -1.20b / Total Liabilities 207.6m |
| Total Rating: -9.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.15
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 0.30% = 0.15 |
| 3. FCF Margin 1.55% = 0.39 |
| 4. Debt/Equity 0.06 = 2.50 |
| 5. Debt/Ebitda -1.89 = -2.50 |
| 6. ROIC - WACC (= -22.98)% = -12.50 |
| 7. RoE -12.17% = -2.03 |
| 8. Rev. Trend 72.98% = 5.47 |
| 9. EPS Trend 33.45% = 1.67 |
What is the price of GENI shares?
Over the past week, the price has changed by -2.23%, over one month by -5.03%, over three months by +27.65% and over the past year by +55.25%.
Is Genius Sports a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GENI is around 11.33 USD . This means that GENI is currently overvalued and has a potential downside of -7.74%.
Is GENI a buy, sell or hold?
- Strong Buy: 11
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GENI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.7 | 19.3% |
| Analysts Target Price | 14.7 | 19.3% |
| ValueRay Target Price | 12.8 | 3.9% |
Last update: 2025-09-04 04:38
GENI Fundamental Data Overview
CCE Cash And Equivalents = 221.6m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 104.1667
P/S = 5.3885
P/B = 4.1785
Beta = 1.868
Revenue TTM = 558.4m USD
EBIT TTM = -85.9m USD
EBITDA TTM = -23.2m USD
Long Term Debt = 40.0m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 3.77m USD (from shortTermDebt, last quarter)
Debt = 43.8m USD (Calculated: Short Term 3.77m + Long Term 40.0m)
Net Debt = -191.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.83b USD (3.01b + Debt 43.8m - CCE 221.6m)
Interest Coverage Ratio = -1074 (Ebit TTM -85.9m / Interest Expense TTM 80.0k)
FCF Yield = 0.30% (FCF TTM 8.63m / Enterprise Value 2.83b)
FCF Margin = 1.55% (FCF TTM 8.63m / Revenue TTM 558.4m)
Net Margin = -13.94% (Net Income TTM -77.9m / Revenue TTM 558.4m)
Gross Margin = 23.50% ((Revenue TTM 558.4m - Cost of Revenue TTM 427.2m) / Revenue TTM)
Tobins Q-Ratio = -2.35 (set to none) (Enterprise Value 2.83b / Book Value Of Equity -1.20b)
Interest Expense / Debt = 0.18% (Interest Expense 80.0k / Debt 43.8m)
Taxrate = 21.0% (US default)
NOPAT = -85.9m (EBIT -85.9m, no tax applied on loss)
Current Ratio = 2.35 (Total Current Assets 394.6m / Total Current Liabilities 167.6m)
Debt / Equity = 0.06 (Debt 43.8m / last Quarter total Stockholder Equity 720.1m)
Debt / EBITDA = -1.89 (Net Debt -191.0m / EBITDA -23.2m)
Debt / FCF = 5.07 (Debt 43.8m / FCF TTM 8.63m)
Total Stockholder Equity = 639.7m (last 4 quarters mean)
RoA = -8.39% (Net Income -77.9m, Total Assets 927.8m )
RoE = -12.17% (Net Income TTM -77.9m / Total Stockholder Equity 639.7m)
RoCE = -12.64% (Ebit -85.9m / (Equity 639.7m + L.T.Debt 40.0m))
RoIC = -13.43% (NOPAT -85.9m / Invested Capital 639.7m)
WACC = 9.54% (E(3.01b)/V(3.05b) * Re(9.68%)) + (D(43.8m)/V(3.05b) * Rd(0.18%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 96.97 | Cagr: 2.16%
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.43% ; FCFE base≈8.63m ; Y1≈5.67m ; Y5≈2.59m
Fair Price DCF = 0.17 (DCF Value 39.7m / Shares Outstanding 238.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 33.45 | EPS CAGR: -11.46% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.98 | Revenue CAGR: 16.15% | SUE: 0.11 | # QB: 0
Additional Sources for GENI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle